Preparing For A Biosimilars Future

By Sonia Oskouei

In the last two decades, the life sciences industry has made incredible progress in the development of innovator biologic treatments. But despite these significant scientific advancements, the cost of developing these critical therapies and ensuring patient accessibility and affordability has remained a challenge — a challenge that many hope can be rectified by the promise of biosimilars.